Position in INVA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,046,829
-$50,171 QoQ
Shares Held
90,129
+0.1% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#76
of 307 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Janney Montgomery Scott LLC holds $121,989,266 across 55 Biotechnology names. INVA ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
85,735 | $42,587,146 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,064,498 | $16,536,628 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,176 | $7,592,223 | |
| 4 | INCY |
Incyte Corp
|
52,727 | $5,977,132 | |
| 5 | EXEL |
Exelixis, Inc.
|
89,664 | $4,878,618 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
272,194 | $3,903,261 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
13,087 | $3,203,304 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
79,550 | $2,815,274 |
All Filings in INVA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,046,829 | 90,129 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,097,000 | 90,000 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,499,250 | 75,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,825,000 | 100,000 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||